ES483978A1 - Procedimiento para la obtencion de derivados de acido hidro-xialcanoico - Google Patents

Procedimiento para la obtencion de derivados de acido hidro-xialcanoico

Info

Publication number
ES483978A1
ES483978A1 ES483978A ES483978A ES483978A1 ES 483978 A1 ES483978 A1 ES 483978A1 ES 483978 A ES483978 A ES 483978A ES 483978 A ES483978 A ES 483978A ES 483978 A1 ES483978 A1 ES 483978A1
Authority
ES
Spain
Prior art keywords
arthritic
manufacture
processes
pharmaceutical compositions
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483978A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES483978A1 publication Critical patent/ES483978A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Procedimiento que a temperatura de 0 a 100ºC, y particularmente conveniente, de 15 a 30ºC. El procedimiento se realiza en un disolvente inerte apropiado, por ejemplo, dimetilformamida, dimetilsulfóxido, o hexametilfosforoamida, optativamente junto con, por ejemplo, tetrahidrofurano. Alternativamente, se puede usar un alconol C1-6'', por ejemplo etanol, como disolvente, comprendiéndose que cuando R3 es un radical alquilo C1-6 que no corresponde al alcanol C1-6 que se usa como disolvente, puede producirse algún intercambio de éster. Podrá apreciarse que cuando R3 es hidrógeno, es necesario emplear al menos dos equivalentes moleculares de la sal de adición de base del compuesto, **(Fórmula)** en la que Hal es un radical cloro, bromo o yodo, se hace reaccionar con una sal de adición de base.
ES483978A 1978-09-08 1979-09-07 Procedimiento para la obtencion de derivados de acido hidro-xialcanoico Expired ES483978A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7836173 1978-09-08

Publications (1)

Publication Number Publication Date
ES483978A1 true ES483978A1 (es) 1980-04-16

Family

ID=10499548

Family Applications (2)

Application Number Title Priority Date Filing Date
ES483978A Expired ES483978A1 (es) 1978-09-08 1979-09-07 Procedimiento para la obtencion de derivados de acido hidro-xialcanoico
ES483977A Expired ES483977A1 (es) 1978-09-08 1979-09-07 Procedimiento para la obtencion de derivados de acido hidroxiacetico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES483977A Expired ES483977A1 (es) 1978-09-08 1979-09-07 Procedimiento para la obtencion de derivados de acido hidroxiacetico

Country Status (27)

Country Link
US (2) US4310544A (es)
EP (1) EP0009306B1 (es)
JP (2) JPS5538385A (es)
AT (1) ATE1855T1 (es)
AU (1) AU522183B2 (es)
BE (2) BE878594A (es)
CA (1) CA1142542A (es)
CS (1) CS212244B2 (es)
DD (1) DD145747A5 (es)
DE (3) DE2964097D1 (es)
DK (1) DK369579A (es)
ES (2) ES483978A1 (es)
FI (1) FI792564A (es)
FR (2) FR2468574A1 (es)
GB (1) GB2031406B (es)
GR (1) GR65651B (es)
IE (1) IE48791B1 (es)
IL (1) IL58074A (es)
IT (1) IT1122501B (es)
NL (2) NL7906339A (es)
NO (1) NO792589L (es)
PH (1) PH14631A (es)
PL (2) PL124197B1 (es)
PT (1) PT70146A (es)
SE (2) SE7907311L (es)
ZA (1) ZA794088B (es)
ZW (1) ZW15179A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2073178B (en) * 1980-04-03 1984-01-25 Ici Ltd Dioxolane derivatives
FR2514355A1 (fr) * 1981-10-14 1983-04-15 Fabre Sa Pierre Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments
IL115995A0 (en) * 1994-11-15 1996-01-31 Bayer Ag Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
EP1083891B1 (en) 1998-06-02 2003-03-12 Arthromics PLC Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
EP2231139B1 (en) * 2008-01-11 2015-02-25 Shanghai Institute of Pharmaceutical Industry Therapeutic formulations based on asiatic acid and selected salts thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
DE2358789A1 (de) * 1973-02-07 1975-06-05 Merck Patent Gmbh Hydratropasaeure-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FI792564A (fi) 1980-03-09
BE878595A (fr) 1980-03-04
FR2468574B1 (es) 1983-04-22
EP0009306B1 (en) 1982-11-24
GB2031406A (en) 1980-04-23
FR2468574A1 (fr) 1981-05-08
DE2934398A1 (de) 1980-06-12
IT1122501B (it) 1986-04-23
SE7907311L (sv) 1980-03-09
JPS5538385A (en) 1980-03-17
US4304788A (en) 1981-12-08
IE48791B1 (en) 1985-05-15
CS212244B2 (en) 1982-03-26
GB2031406B (en) 1982-06-16
DE2964097D1 (en) 1982-12-30
JPS5538384A (en) 1980-03-17
ES483977A1 (es) 1980-04-16
DK369579A (da) 1980-03-09
PT70146A (en) 1979-10-01
DD145747A5 (de) 1981-01-07
IE791510L (en) 1980-03-08
PH14631A (en) 1981-10-12
ZA794088B (en) 1980-08-27
SE7907390L (sv) 1980-03-09
FR2468575A1 (fr) 1981-05-08
US4310544A (en) 1982-01-12
IT7925221A0 (it) 1979-08-21
SE437262B (sv) 1985-02-18
ATE1855T1 (de) 1982-12-15
IL58074A0 (en) 1979-12-30
BE878594A (fr) 1980-03-04
GR65651B (en) 1980-10-16
CA1142542A (en) 1983-03-08
AU522183B2 (en) 1982-05-20
FR2468575B1 (es) 1983-02-18
EP0009306A1 (en) 1980-04-02
NL7906339A (nl) 1980-03-11
PL117130B1 (en) 1981-07-31
IL58074A (en) 1982-07-30
DE2934375A1 (de) 1980-06-12
AU4975379A (en) 1980-03-13
NO792589L (no) 1980-03-11
NL7906554A (nl) 1980-03-11
ZW15179A1 (en) 1981-03-18
PL124197B1 (en) 1982-12-31
PL217978A1 (es) 1980-04-21

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
IL57392A (en) 7-(2-(2-aminothiazolyl)-(2-methoxyimino))acetamido-3-(di-and tetrahydrotriazinyl)thiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES483978A1 (es) Procedimiento para la obtencion de derivados de acido hidro-xialcanoico
BE904517A (fr) Esters d'alceneamidocephalosporines.
ATE15045T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
HUT37126A (en) Pocess for the production of new amino-ethyl-imidazola-derivatives, as well as of pharmaceutical preparations containing thes compounds
ATE1585T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate.
TH4132EX (th) เอสเทอร์ของ 7 เบต้า-(2-(2-อะมิโน-4-ไธอาซอลิ)-2-แอลเคโนอิลอะมิโน)-3-เซเฟม-4-คาร์บอกซิลิค แอซิด